core diabetes model version 8.5 (IQVIA Inc)
90
Structured Review
IQVIA Inc
core diabetes model version 8.5
Core Diabetes Model Version 8.5, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+diabetes+model+version+8%2E5/core+diabetes+model+version+9+0/pmc06594226-87-19-24
Average 90 stars, based on 1 article reviews
Core Diabetes Model Version 8.5, supplied by IQVIA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/core+diabetes+model+version+8%2E5/core+diabetes+model+version+9+0/pmc06594226-87-19-24
Average 90 stars, based on 1 article reviews
core diabetes model version 8.5 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Switching from sitagliptin to liraglutide to manage patients with type 2 diabetes in the UK: A long-term cost-effectiveness analysis. Article Snippet: A cc ep te d A rti cl e Article Title: Evaluating the long‐term cost‐effectiveness of fixed‐ratio combination insulin degludec/liraglutide (IDegLira) for type 2 diabetes in Spain based on real‐world clinical evidence Article Snippet: Long‐term projections of costs and clinical outcomes based on data from the EXTRA study were made using the IQVIA Article Title: The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden Article Snippet: The present study was performed using |